Avid Bioservices Inc (CDMO)

[itsabouttime]

The Loncar Cancer Immunotherapy Index (LCINDX) seeks to track the combined performance of a basket of companies that develop therapies to treat cancer by harnessing the body's own immune system. Immunotherapy is a transformational field within the biotechnology space. The index will provide a metric to follow its progress as researchers advance new technologies for the benefit of courageous patients who fight the disease. It is an equal-weighted index containing both large pharmaceutical and growth-oriented biotechnology companies that are leading in this approach



It would be nice to be added to this index at some point.


Index Constituents


Novartis


Merck


Amgen


Bristol Myers


Celgene


AstraZeneca


Incyte


Juno Therapeutics


bluebird bio


Kite Pharma


Celldex Therapeutics


TESARO


NewLink Genetics


ZIOPHARM


Cellectis


MacroGenics


Bellicum


Five Prime Therapeutics


Atara Biotherapeutics


Sorrento Therapeutics


Agenus


Northwest Biotherapeutics


Lion Biotechnologies


Inovio Pharma


Advaxis